Concentrations of amyloid-beta protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease

Neurosci Lett. 1994 May 19;172(1-2):122-4. doi: 10.1016/0304-3940(94)90677-7.

Abstract

Cerebral deposition of amyloid-beta protein (A beta) is central to the pathogenesis of Alzheimer's disease (AD). Increasing age is one of the few definitively established risk factors for this disease. The concentration of A beta was measured in cerebrospinal fluid (CSF) with a sensitive enzyme-linked immunosorbent assay in 18 adult neurological patients free from neurodegenerative disease. CSF A beta increased with age, yielding a significant correlation of 0.84. This observation suggests that increased levels of A beta in CSF may be an index of age-related changes in the processing of the amyloid-beta precursor protein resulting in an increased risk for AD.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / cerebrospinal fluid*
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Middle Aged
  • Nervous System Diseases / cerebrospinal fluid*

Substances

  • Amyloid beta-Peptides